The Los Alamos Trapped Ion Quantum Computer Experiment

The development and theory of an experiment to investigate quantum computation with trapped calcium ions is described. The ion trap, laser and ion requirements are determined, and the parameters required for quantum logic operations as well as simple quantum factoring are described.Comment: 41 pages, 16 figures, submitted to Fortschritte der Physi

Characterization of the englacial and subglacial drainage system in a high Arctic cold glacier by speleological mapping and ground-penetrating radar

This paper presents new data obtained by speleological surveys and ground-penetrating radar (GPR) on a cut-and-closure conduit in Scott Turnerbreen, a small cold glacier in Svalbard, Norwegian Arctic. We use these data to propose criteria for the identification of cut-and-closure conduits from GPR data. In addition, we describe subglacial and englacial structures exposed in the conduit, which shed light on the former dynamic behaviour of the glacier. The glacier bed consists of a thick layer of subglacial traction till, from which till-filled fractures extend upward into the ice. These observations show that Scott Turnerbreen was formerly warm-based, and are consistent with a surge or surge-like behaviour. The channel system was also imaged using GPR. Varying channel morphologies have distinctive signatures on GPR profiles, allowing the identification and mapping of englacial drainage systems in situations where direct access is impossible.PostprintPeer reviewe

Observation of power-law scaling for phase transitions in linear trapped ion crystals

We report an experimental confirmation of the power-law relationship between the critical anisotropy parameter and ion number for the linear-to-zigzag phase transition in an ionic crystal. Our experiment uses laser cooled calcium ions confined in a linear radio-frequency trap. Measurements for up to 10 ions are in good agreement with theoretical and numeric predictions. Implications on an upper limit to the size of data registers in ion trap quantum computers are discussed.Comment: Physical Review Letters in press, 4 pages, 4 figure

Role of negative ion resonances in electron scattering from atoms and molecules

Transient negative ions (resonances) formed during the collision of an electron with an atom or molecule have been extensively studied for over thirty years. The continued interest in these states, both experimentally and theoretically, stems from the profound effects that they can have on electron scattering cross sections and the role that electron-electron correlations play in their formation and quasi-stability. A selective discussion of examples of such resonances, involving one, two and three excited electrons is given for a wide range of atomic and molecular systems. © CSIRO 1999

The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of prostate carcinoma.

Prostate cancer is the most commonly diagnosed malignancy and second leading cause of cancer death among men in the United States. In recent years, several new agents, including cancer immunotherapies, have been approved or are currently being investigated in late-stage clinical trials for the management of advanced prostate cancer. Therefore, the Society for Immunotherapy of Cancer (SITC) convened a multidisciplinary panel, including physicians, nurses, and patient advocates, to develop consensus recommendations for the clinical application of immunotherapy for prostate cancer patients. To do so, a systematic literature search was performed to identify high-impact papers from 2006 until 2014 and was further supplemented with literature provided by the panel. Results from the consensus panel voting and discussion as well as the literature review were used to rate supporting evidence and generate recommendations for the use of immunotherapy in prostate cancer patients. Sipuleucel-T, an autologous dendritic cell vaccine, is the first and currently only immunotherapeutic agent approved for the clinical management of metastatic castrate resistant prostate cancer (mCRPC). The consensus panel utilized this model to discuss immunotherapy in the treatment of prostate cancer, issues related to patient selection, monitoring of patients during and post treatment, and sequence/combination with other anti-cancer treatments. Potential immunotherapies emerging from late-stage clinical trials are also discussed. As immunotherapy evolves as a therapeutic option for the treatment of prostate cancer, these recommendations will be updated accordingly

Dynamical Stability and Quantum Chaos of Ions in a Linear Trap

The realization of a paradigm chaotic system, namely the harmonically driven oscillator, in the quantum domain using cold trapped ions driven by lasers is theoretically investigated. The simplest characteristics of regular and chaotic dynamics are calculated. The possibilities of experimental realization are discussed.Comment: 24 pages, 17 figures, submitted to Phys. Rev

Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group.

Cancer immunotherapy has transformed the treatment of cancer. However, increasing use of immune-based therapies, including the widely used class of agents known as immune checkpoint inhibitors, has exposed a discrete group of immune-related adverse events (irAEs). Many of these are driven by the same immunologic mechanisms responsible for the drugs\u27 therapeutic effects, namely blockade of inhibitory mechanisms that suppress the immune system and protect body tissues from an unconstrained acute or chronic immune response. Skin, gut, endocrine, lung and musculoskeletal irAEs are relatively common, whereas cardiovascular, hematologic, renal, neurologic and ophthalmologic irAEs occur much less frequently. The majority of irAEs are mild to moderate in severity; however, serious and occasionally life-threatening irAEs are reported in the literature, and treatment-related deaths occur in up to 2% of patients, varying by ICI. Immunotherapy-related irAEs typically have a delayed onset and prolonged duration compared to adverse events from chemotherapy, and effective management depends on early recognition and prompt intervention with immune suppression and/or immunomodulatory strategies. There is an urgent need for multidisciplinary guidance reflecting broad-based perspectives on how to recognize, report and manage organ-specific toxicities until evidence-based data are available to inform clinical decision-making. The Society for Immunotherapy of Cancer (SITC) established a multidisciplinary Toxicity Management Working Group, which met for a full-day workshop to develop recommendations to standardize management of irAEs. Here we present their consensus recommendations on managing toxicities associated with immune checkpoint inhibitor therapy